RETRACTED ARTICLE: Clostridium difficile toxin B induces colonic inflammation through the TRIM46/DUSP1/MAPKs and NF-κB signalling pathway
Open Access
- 1 January 2020
- journal article
- retracted article
- Published by Taylor & Francis Ltd in Artificial Cells, Nanomedicine, and Biotechnology
- Vol. 48 (1), 452-462
- https://doi.org/10.1080/21691401.2019.1709856
Abstract
Clostridium difficile (C. difficile) infection results in toxin-induced epithelial injury and marked colonic inflammation. Mitogen-activated protein kinase (MAPK) and NF-κB which regulated by MAP kinase phosphatase (MKP, also known as dual specificity phosphatases, DUSP) are fundamental signalling pathways that mediate multiple cellular processes. However, the regulation of DUSP/MAPKs and NF-κB pathway in C. difficile-induced colonic inflammation remains unclear. Here, we report that TcdB significantly inhibits cell viability and induces production of IL-1β and TNF-α and activation of MAPKs and NF-κB. An E3-ubiquitin ligase, TRIM46, ubiquitinates DUSP1, and its knockdown significantly inhibit TcdB-induced activation of MAPKs and NF-κB and production of IL-1β and TNF-α. Moreover, TRIM46 overexpression induced production of IL-1β and TNF-α also reversed by DUSP1 overexpression. We further found that promoter of TRIM46 also demonstrated binding to NF-κBp65, leading to regulate TRIM46 expression. In addition, the increased colonic inflammation induced by C. difficile administration was inhibited by TRIM46 knockdown in vivo. Taken together, the present study shows that TRIM46, as a new regulator of DUSP1/MAPKs and NF-κB signalling pathway, plays an important role in TcdB-induced colonic inflammation.Keywords
Funding Information
- National Natural Science Foundation of China (8180080671, 81603163, 18ZR1405500)
This publication has 39 references indexed in Scilit:
- TRIM11 Negatively Regulates IFNβ Production and Antiviral Activity by Targeting TBK1PLOS ONE, 2013
- Intrarectal Instillation of Clostridium difficile Toxin A Triggers Colonic Inflammation and Tissue Damage: Development of a Novel and Efficient Mouse Model of Clostridium difficile Toxin ExposureInfection and Immunity, 2012
- Targeted Restoration of the Intestinal Microbiota with a Simple, Defined Bacteriotherapy Resolves Relapsing Clostridium difficile Disease in MicePLoS Pathogens, 2012
- Dual‐specificity MAP kinase phosphatases (MKPs)The FEBS Journal, 2012
- Tripartite motif 8 (TRIM8) modulates TNFα- and IL-1β–triggered NF-κB activation by targeting TAK1 for K63-linked polyubiquitinationProceedings of the National Academy of Sciences of the United States of America, 2011
- Identification of tripartite motif-containing 22 (TRIM22) as a novel NF-κB activatorBiochemical and Biophysical Research Communications, 2011
- The Human Microbiome ProjectNature, 2007
- Diarylheptanoids from Alnus hirsuta Inhibit the NF-kB Activation and NO and TNF-.ALPHA. ProductionBiological & Pharmaceutical Bulletin, 2007
- Toxigenic C. difficile induced inflammatory marker expression by human intestinal epithelial cells is asymmetricalLife Sciences, 2006
- Toxins A and B from Clostridium difficile differ with respect to enzymatic potencies, cellular substrate specificities, and surface binding to cultured cells.JCI Insight, 1997